Table 2 Adjusted mean baseline biomarker values for groups of Black and white individuals

From: Baseline levels and longitudinal changes in plasma Aβ42/40 among Black and white individuals

Biomarker

Group

N

Mean

adjusted value

Standard

error

p

Plasma Aβ42/Aβ40

Black

214

0.1201

0.0030

 

White

1113

0.1155

0.0030

 

Difference (Black–white)

 

0.0046

0.0008

<0.0001

Plasma Aβ42 (pg/mL)

Black

214

26.25

2.40

 

White

1113

26.41

2.36

 

Difference (Black–white)

 

−0.16

0.61

0.80

Plasma Aβ40 (pg/mL)

Black

214

177.8

22.7

 

White

1113

199.5

22.4

 

Difference (Black–white)

 

−21.6

5.7

0.0002

Amyloid PET Centiloid

Black

89

21.6

13.6

 

White

626

28.2

13.4

 

Difference (Black–white)

 

−6.6

3.7

0.072

CSF Aβ42/40

Black

80

0.1122

0.0068

 

White

806

0.1069

0.0068

 

Difference (Black–white)

 

0.0053

0.0021

0.014

CSF Aβ42 (pg/mL)

Black

80

840

117

 

White

806

915

116

 

Difference (Black–white)

 

−75

37

0.041

CSF Aβ40 (pg/mL)

Black

80

5552

1277

 

White

806

7284

1272

 

Difference (Black–white)

 

−1732

400

<0.0001

CSF t-tau (pg/mL)

Black

80

114.2

83.1

 

White

806

198.1

82.9

 

Difference (Black–white)

 

−84.0

26.1

0.001

CSF p-tau181 (pg/mL)

Black

80

17.42

12.31

 

White

806

28.46

12.27

 

Difference (Black–white)

 

−11.04

3.86

0.004

  1. The linear regression models included the main effects of race and the covariates of age, sex, APOE ε4 carrier status, years of education, cognitive status (unimpaired, CDR 0; or impaired, CDR > 0), fasting status if plasma biomarker (fasting or non-fasting), BMI, and status for hypertension, diabetes, and stroke (positive or negative). The two-sided t-test raw p-values testing for the significance of differences between the Black and white groups are shown.